Another research shows that ALB was significantly lower in patients with active disease (P < 0.01), and C-reactive protein/albumin ratio (CAR) is a useful biomarker for identifying disease activity in patients with IBD (AUC = 0.829) (37), which is similar to our study results. This evidence concerns the gene CRP and inflammatory bowel disease.